Quisinostat is a brain-penetrant radiosensitizer in glioblastoma
C. Lo Cascio, T. Margaryan, E. L. Melendez, J. B. McNamara, C. I. White, W. Knight, S. Ganta, Z. Opachich, W. Yoo, N. Sanai, S. Mehta, A. Tovmasyan
This study shows that quisinostat, a selective HDAC1/2 inhibitor, is brain-penetrant and enhances radiation therapy efficacy in glioblastoma models.
JCI Insight · Nov 22, 2023Peer-reviewedCancer Biology